Author(s):
Vijaya S. Vichare, Vishnu P. Choudhari, M. Venkata Reddy
Email(s):
vicharevijaya11@gmail.com
DOI:
10.52711/0974-360X.2022.00434 
Address:
Vijaya S. Vichare1,4, Vishnu P. Choudhari2,4, M. Venkata Reddy3,4
1PES Modern College of Pharmacy (for Ladies), Moshi, Pune, Maharashtra, India.
2School of Pharmacy, MIT World Peace University, Pune, Maharashtra, India.
3Sree Datta Institute of Pharmacy, Sheriguda, Ibrahimpattanam, Telangana, India.
4Department of Pharmaceutical Sciences, Jawaharlal Nehru Technological University, Hyderabad, Telangana, India.
*Corresponding Author
Published In:
Volume - 15,
Issue - 6,
Year - 2022
ABSTRACT:
A new HPTLC method for simultaneous determination of Canagliflozin and Metformin was developed, validated and compared with the reported one. An excellent resolution with Rf values 0.21±0.02 and 0.50±0.03 for Metformin and Canagliflozin respectively was achieved by using optimized chromatographic conditions. Toluene: Methanol: Triethyl amine: Glacial Acetic acid (7:2.6:0.2:0.2, v/v/v/v) was chosen as a mobile phase. Detection was done at 254nm. When marketed formulation was analyzed by developed method, the % drug contents were found to be 98.20±0.24 and 99.33±1.80% w/w for Metformin and Canagliflozin respectively. Developed method was validated for linearity and range, DL, QL, accuracy, precision, robustness and specificity. The method was found to be linear, accurate, precise, robust and sensitive. The method was found to be linear in a range of 75-750ng/band of Canagliflozin with R2 value 0.9981 and 250-2500ng/band of Metformin with R2 value 0.9963. Detection and quantitation limits were found to be 8.01 and 24.28ng/band for Metformin and 8.27 and 25.07ng/band for Canagliflozin respectively. The % drug recovery was calculated as a measure of accuracy. The % drug recovery was found to be near to 100 %w/w confirmed the accuracy of the method. In case of precision studies, %RSD values were found to be less than two indicated, the method is precise. The % RSD values of deliberate variations like amount of mobile phase, saturation time were found to be less than two showed method is robust. The developed method was compared with the reported method and found to be more linear, accurate, precise and sensitive.
Cite this article:
Vijaya S. Vichare, Vishnu P. Choudhari, M. Venkata Reddy. Development of new Validated HPTLC Method for simultaneous estimation of Canagliflozin and Metformin in Tablet Formulation. Research Journal of Pharmacy and Technology. 2022; 15(6):2599-4. doi: 10.52711/0974-360X.2022.00434
Cite(Electronic):
Vijaya S. Vichare, Vishnu P. Choudhari, M. Venkata Reddy. Development of new Validated HPTLC Method for simultaneous estimation of Canagliflozin and Metformin in Tablet Formulation. Research Journal of Pharmacy and Technology. 2022; 15(6):2599-4. doi: 10.52711/0974-360X.2022.00434 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2022-15-6-38
REFERENCES:
1. www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process, visited on (accessed on Dec 7, 2017).
2. Tripathi KD. Essentials of Medical Pharmacology. Jaypee Brothers Medical Publishers Ltd. New Dehli, India. 2001; 4th ed: pp. 279.
3. Indian Pharmacopoeia, Vol-II, Government of India, Ministry of Health and family welfare. Published by Indian Pharmacopoeia Commission, Ghaziabad, 2014; pp. 2186-2187.
4. British Pharmacopoeia, Vol-II, The Stationary Office on behalf of Medicines and Health Care Products Regulatory Agency (MHRA), London, United Kingdom, 2008; pp. 1410-1411.
5. United States Pharmacopoeia-34 National Formulary-29, Vol-III, United States Pharmacopoeial Convection, Rockville, 2011; pp. 3442.
6. www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204353 (accessed on Dec 7, 2017).
7. Fixed dose combinations approved by DCG(I) since 1961 to June 2019 (https://cdsco.gov.in>resources , visited on Oct 10 2018)
8. Mubeen G, Khalikha N. Spectrophotometric method for analysis of metformin hydrochloride. Indian Journal of Pharmaceutical Sciences. 2009;71(1):100-102.
9. Arayne MS et al. Spectrophotometric quantitation of metformin in bulk drug and pharmaceutical formulations using multivariate technique. Indian Journal of Pharmaceutical Sciences. 2009;71(3):331–335.
10. Patil PM et al. Direct spectrophotometric determination of metformin hydrochloride in pure form and in pharmaceutical formulations. Research J. Pharm. and Tech. 2009;2(4):874-875.
11. Umapathi P et al. Quantitative determination of metformin hydrochloride in tablet formulation containing croscarmellose sodium as disintegrant by HPLC and UV spectrophotometry. Tropical Journal of Pharmaceutical Research. 2012;11(1):107-116.
12. Rajan VR. UV spectrophotometric estimation of metformin hydrochloride by area under curve methods in bulk and pharmaceutical dosage form. Asian J. Research Chem. 2019;12(3):187-190.
13. Daharwal SJ et al. Comparative evaluation of marketed formulations of Metformin HCl available in India. Asian J. Research Chem. 2015;8(7):441-444.
14. Rajan VR, Prathamesh PT. Derivative UV spectrophotometric method for validation of metformin hydrochloride in bulk and pharmaceutical dosage form. Asian J. Research Chem. 2019;12(6):351-354.
15. Kaur I et al. Development and validation of UV spectroscopic method for determination of canagliflozin in bulk and pharmaceutical dosage form. Pharm Methods. 2015;6(2):82-86.
16. Kaur I et al. Development and validation of stability indicating UV spectroscopic method for determination of canagliflozin in bulk and pharmaceutical dosage form. Pharm Methods. 2016;7(1):63-69.
17. KrupaKarunaVani B. Extractive visible spectrophotometric method development and validation for the estimation of canagliflozin in pharmaceutical formulations. The Experiment. 2017;40(3):2376-2381.
18. Krupa Karuna Vani B. UV and derivative spectrophotometry method for the estimation of canagliflozin in pharmaceutical formulations. International Journal of Applied Pharmaceutical Sciences and Biological Sciences. 2017;6(1):022-029.
19. Vichare VS et al. Development and validation of UV-Visible spectroscopic methods for simultaneous estimation of canagliflozin and metformin in pharmaceutical formulation. Asian J. Research Chem. 2019;12(1):16-20.
20. Maddu S et al. RP-HPLC method development and validation for the estimation of canagliflozin in tablet dosage form. Int J Pharm. 2014;5(4):1288-1292.
21. Suneetha A and Sharmila D. Validated stability indicating RP-HPLC method for estimation of canagliflozin in dosage form. Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2015;6(5):1186.
22. Panigrahy UP, Sunil Kumar RA. A novel validated RP HPLC DAD method for the simultaneous estimation of metformin hydrochloride and canagliflozin in bulk and pharmaceutical tablet dosage form with forced degradation studies. Oriental Journal of Chemistry. 2015;31(3):1489-1507.
23. Dudhe PB, Kamble MC. RP-HPLC method development and validation for the determination of canagliflozin in human plasma. International Journal of PharmTech Research. 2016;9(8):174-181.
24. Kaur I et al. Development and validation of a stability-indicating reverse phase HPLC-PDA method for determination of canagliflozin in bulk and pharmaceutical dosage form. Pharm Methods. 2016;7(1):54-62.
25. D’souza S et al. Stability indicating assay method development and validation to simultaneously estimate metformin hydrochloride and canagliflozin by RP-HPLC. Current Trends in Biotechnology and Pharmacy. 2016;10(4):334-342.
26. Marella VL et al. A novel validated RP-HPLC method for the estimation of canagliflozin in bulk and pharmaceutical dosage forms. International Journal of Advances in Pharmaceutical Analysis. 2017;7(3):24-27.
27. Sen G et al. Validation of stability indicating reverse phase HPLC method for the determination of related substances in canagliflozin drug substance. IOSR Journal of Pharmacy and Biological Sciences. 2017;12(6):86-94.
28. Wafaa AZ et al. Comparative liquid chromatographic study for concurrent determination of canagliflozin and metformin in combined tablets. Hindawi Journal of Analytical Methods in Chemistry. 2017;1-9.
29. Kommineni V et al. Development of a new stability indicating RP-HPLC method for simultaneous estimation of metformin hydrochloride and canagliflozin and its validation as per ICH guidelines. Int Journal of Pharm Sci and Research. 2017;8(8):3427-3435.
30. Uppalapati J, Parimi U. Analytical method development and validation for the simultaneous estimation of canagliflozin and metformin in drug product by RP-HPLC. European Journal of Biomedical and Pharmaceutical Sciences. 2017;4(11):298-303.
31. Sushil DP, Shaikh AM, Sanjay JK. Review study on Canagliflozin. Asian J. Research Chem. 2018;11(5):819-823.
32. Gandla KS et al. A validated RP-HPLC method for simultaneous determination of metformin and canagliflozin in pharmaceutical formulation. Asian Journal of Pharmaceutical Analysis. 2018;8(2):73-77.
33. Sushil DP, Shaikh AM, Sanjay JK. Development and validation of stability indicating RP-HPLC method for canagliflozin. Asian J. Research Chem. 2019;12(1):11-15.
34. Nachiket SD et al. Simultaneous estimation and validation of canagliflozin and metformin hydrochloride in bulk and pharmaceutical dosage form by using RP-HPLC. Research J Pharm and Tech. 2019;12(10):4953-4957.
35. Rawa Akasha et al. Characterization of the global metabolic profile of Canagliflozin in Rat plasma, urine and feces based on HPLCUV-MS Analysis. Research J. Pharm. and Tech. 2020;13(1):399-403.
36. Kaur I et al. Development and validation of a stability-indicating high performance thin layer chromatography (HPTLC) method for estimation of canagliflozin in bulk and pharmaceutical dosage form. Journal of Applied Pharmaceutical Science. 2016;6(05):051-057.
37. Aml AE. Canagliflozin stability study and eco-friendly chromatographic determination of its degradation product: a comparative study. Journal of Separation Science. 2017;41(4):822-830.
38. Bhole RP, Gandhi JS, Wankhede S. Development and validation of HPTLC method for simultaneous estimation of canagliflozin and metformin hydrochloride in bulk and tablet dosage form. South African Pharmaceutical Journal. 2017;84(6):65-71.